Understanding what happens to therapeutic antibodies and antibody-drug conjugates (ADCs) after they enter a cell is critical to designing targeted […]
Commercial-scale Photo Flow Chemistry successfully executed in Bidar
30 Apr 2026
Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a US-based innovator. This execution builds on prior investments in continuous processing infrastructure at the site, including a 3-litre photo flow reactor equipped with a monochromatic blue LED light source. The platform enables controlled photochemical transformations at kilogram scale and supports improved thermal management and reaction consistency compared to conventional batch processing.
Flow chemistry is applied where it offers clear advantages — particularly in the handling of hazardous intermediates, control of highly exothermic reactions, and management of light-driven transformations. Its integration into late-phase development and commercial manufacturing workflows supports safer scale-up and stronger process robustness.
The expansion strengthens our ability to incorporate continuous processing strategies into large-scale API programs where scientifically appropriate, supporting reliable execution through development and GMP manufacture.
Related News
Sai Life Sciences plans to set up a new oral solid formulation facility to support small-molecule programs entering early clinical […]
27 Aug 2026
We have successfully scaled up a late-stage GMP intermediate for a large pharmaceutical customer using flow chemistry, marking another step […]